Opening Day: Cancer 'Killer' Nkarta Soars After Coming Public By: TalkMarkets July 12, 2020 at 14:44 PM EDT Nkarta, which is developing "natural killer-based cell therapies" to treat cancer saw its stock surge on its first day of public trading. Read More >> Related Stocks: Poseida Therapeutics Inc